IL11 signaling mediates piR-2158 suppression of cell stemness and angiogenesis in breast cancer

  • Impact factors: 5.4
  • Publication: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
  • Author:Zhuoxiao Han, Jiao Ma, Ying Han, Guanli Yuan, Rui Jiao, Aihong Meng
  • DOI citation-doi:10.3892/ijmm.2023.5235
  • Date:2023-03-07T00:00:00.000Z

Emerging evidence has indicated the aberrant expression of PIWI-interacting RNAs (piRNAs) in human cancer cells to regulate tumor development and progression by governing cancer cell stemness. Herein, we identified downregulation of piR-2158 in human breast cancer tumors, especially in ALDH+ breast cancer stem cells (BCSCs) from patients and cell lines, which was further validated in two types of genetically engineered mouse models of breast cancer (MMTV-Wnt and MMTV-PyMT). Enforced overexpression of piR-2158 in basal-like or luminal subtypes of breast cancer cells suppressed cell proliferation, migration, epithelial-mesenchymal transition (EMT) and stemness in vitro . Administration of a dual mammary tumor-targeting piRNA delivery system in mice reduced tumor growth in vivo . RNA-seq, ChIP-seq and luciferase reporter assays demonstrated piR-2158 as a transcriptional repressor of IL11 by competing with AP-1 transcription factor subunit FOSL1 to bind the promoter of IL11 . STAT3 signaling mediated piR-2158-IL11 regulation of cancer cell stemness and tumor growth. Moreover, by co-culturing of MDA-MB-231 and HUVECs in vitro and CD31 staining of tumor endothelial cells in vivo, we demonstrated inhibition of angiogenesis by piR-2158-IL11 in breast cancer. In conclusion, the current study not only reveals a novel mechanism through which piR-2158 inhibits mammary gland tumorigenesis via regulating cancer stem cells and tumor angiogenesis, but also provides a novel therapeutic strategy in treatment of breast cancer.

Related Products

EK111

$350.00$450.00

Hot products

Hot citation